Stepan Company (SCL)
:SCL
Advertisement

Stepan Company (SCL) AI Stock Analysis

Compare
180 Followers

Top Page

SCL

Stepan Company

(NYSE:SCL)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 4o)
Rating:62Neutral
Price Target:
$47.00
▲(3.39% Upside)
Stepan Company's overall stock score is driven by strong cash flow management and modest revenue growth. However, the low profitability and bearish technical indicators weigh down the score. The earnings call provided mixed signals, with growth in some areas but significant challenges in others.

Stepan Company (SCL) vs. SPDR S&P 500 ETF (SPY)

Stepan Company Business Overview & Revenue Model

Company DescriptionStepan Company (SCL) is a global manufacturer of specialty and intermediate chemicals, serving diverse markets including personal care, household and industrial cleaning, and agricultural products. The company operates through three primary segments: Surfactants, Polymers, and Specialty Products, offering a wide range of products such as surfactants, emulsifiers, and foam control agents. Stepan's commitment to innovation and sustainability is reflected in its extensive portfolio of high-performance chemicals designed to meet the evolving needs of its customers.
How the Company Makes MoneyStepan Company generates revenue primarily through the sale of its specialty and intermediate chemicals. Key revenue streams include the production and sale of surfactants, which are used in cleaning products, personal care items, and agricultural applications. The company also earns revenue from its polymers segment, which provides a variety of plastic additives and coatings. Additionally, Stepan's specialty products segment includes unique chemical formulations for various niche markets. Strategic partnerships with leading brands and manufacturers enhance its distribution capabilities and market reach, while ongoing investments in research and development enable the company to innovate and introduce new products, thereby driving further revenue growth.

Stepan Company Earnings Call Summary

Earnings Call Date:Oct 29, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 25, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mixed view with notable achievements in adjusted EBITDA growth and specialty products, but also highlighted significant challenges in the surfactants segment and a sharp decline in adjusted net income due to tax and depreciation impacts.
Q3-2025 Updates
Positive Updates
Adjusted EBITDA Growth
The company delivered a 9% adjusted EBITDA growth for the first 9 months of 2025, totaling $165 million year-to-date.
Specialty Products Segment Success
Specialty Products adjusted EBITDA increased by 113% due to favorable order timing, and net sales rose by 68% compared to the prior year.
Free Cash Flow Improvement
Free cash flow was positive at $40 million during the quarter, driven by reduced working capital and disciplined capital spending.
Dividend Increase
The Board of Directors declared a quarterly cash dividend of $0.395 per share, a 2.6% increase, marking 58 consecutive years of dividend increases.
Negative Updates
Surfactants Segment Challenges
Surfactants adjusted EBITDA decreased by 14% due to higher startup costs, raw material cost inflation, and lower demand in global commodity consumer products.
Adjusted Net Income Decline
Adjusted net income for the quarter was $10.9 million, down 54% from the previous year due to a higher effective tax rate and increased depreciation.
Polymers Segment Pressure
Polymers net sales decreased by 4%, with adjusted EBITDA down 4% due to lower unit margins and unfavorable mix despite an 8% increase in sales volume.
Oleochemical Raw Material Costs
Significantly higher oleochemical raw material costs impacted surfactant margins, with raw material prices showing a 70% increase compared to 2024.
Company Guidance
During the Stepan Company Third Quarter 2025 Earnings Conference Call, several key metrics were highlighted, providing a comprehensive overview of the company's financial performance and strategic direction. The company reported a 9% growth in adjusted EBITDA for the first nine months of 2025, amounting to $165 million, despite challenges such as increased oleochemical raw material prices and start-up costs at the new Pasadena, Texas facility. Third quarter adjusted EBITDA rose by 6% year-on-year to $56 million, while adjusted net income decreased by 54% to $10.9 million, impacted by a higher effective tax rate, increased interest expenses, and depreciation. Sales volumes grew by 1%, with Polymers up 8% and the NCT product line up 26%, although Surfactants volume declined by 2%. Free cash flow was positive at $40 million, and dividends of $8.7 million were paid to shareholders. The Board declared a quarterly cash dividend of $0.395 per share, marking a 2.6% increase. The new Pasadena site began operations, contributing to future growth, and the company anticipates fully recovering from raw material cost impacts by 2026. Looking ahead, Stepan remains focused on enhancing operational excellence, improving product and customer mix, and delivering positive free cash flow for the full year 2025.

Stepan Company Financial Statement Overview

Summary
Stepan Company shows a modest revenue growth and improved leverage management, but profitability remains a challenge with low net profit margins. The cash flow position is strong, indicating effective cash management.
Income Statement
65
Positive
Stepan Company shows a modest revenue growth rate of 1.92% in the TTM, recovering from a decline in previous years. The gross profit margin is stable at 11.94%, but the net profit margin is relatively low at 1.96%, indicating pressure on profitability. EBIT and EBITDA margins have slightly improved, suggesting operational efficiencies. However, the overall profitability remains a concern due to the low net profit margin.
Balance Sheet
70
Positive
The company's debt-to-equity ratio has improved to 0.29 in the TTM, indicating better leverage management compared to previous years. Return on equity is at 3.72%, which is lower than historical levels, reflecting challenges in generating returns for shareholders. The equity ratio remains stable, suggesting a balanced capital structure. Overall, the balance sheet shows improved leverage but highlights the need for better profitability.
Cash Flow
75
Positive
Free cash flow has grown significantly by 61.15% in the TTM, indicating strong cash generation capabilities. The operating cash flow to net income ratio is healthy at 0.15, and the free cash flow to net income ratio is 0.68, showing efficient cash conversion. The cash flow statement reflects strong cash management and improved liquidity, despite historical volatility in free cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.30B2.18B2.33B2.77B2.35B1.87B
Gross Profit275.07M272.21M277.60M427.07M395.81M383.61M
EBITDA199.73M192.10M169.68M294.24M270.42M260.51M
Net Income45.24M50.37M40.20M147.15M137.80M126.77M
Balance Sheet
Total Assets2.43B2.30B2.36B2.43B2.07B1.75B
Cash, Cash Equivalents and Short-Term Investments118.54M99.67M129.82M173.75M159.19M349.94M
Total Debt357.11M682.83M712.17M637.70M420.25M250.24M
Total Liabilities1.19B1.13B1.15B1.27B991.42M763.97M
Stockholders Equity1.25B1.17B1.22B1.17B1.07B986.69M
Cash Flow
Free Cash Flow119.97M39.28M-85.46M-140.79M-122.35M109.42M
Operating Cash Flow156.18M162.05M174.88M160.76M72.14M235.22M
Investing Cash Flow-117.22M-116.94M-258.67M-308.09M-376.83M-139.03M
Financing Cash Flow-69.19M-64.52M33.28M166.21M117.33M-64.93M

Stepan Company Technical Analysis

Technical Analysis Sentiment
Negative
Last Price45.46
Price Trends
50DMA
46.51
Negative
100DMA
49.72
Negative
200DMA
52.29
Negative
Market Momentum
MACD
-0.80
Negative
RSI
45.78
Neutral
STOCH
66.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SCL, the sentiment is Negative. The current price of 45.46 is above the 20-day moving average (MA) of 44.26, below the 50-day MA of 46.51, and below the 200-day MA of 52.29, indicating a bearish trend. The MACD of -0.80 indicates Negative momentum. The RSI at 45.78 is Neutral, neither overbought nor oversold. The STOCH value of 66.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SCL.

Stepan Company Risk Analysis

Stepan Company disclosed 20 risk factors in its most recent earnings report. Stepan Company reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Stepan Company Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$775.03M15.2021.89%1.17%10.97%36.07%
75
Outperform
$1.10B22.499.47%-9.57%-24.85%
62
Neutral
$999.08M22.353.67%3.49%5.35%-1.43%
62
Neutral
$1.73B-2,090.60-0.09%0.79%-2.53%-100.23%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
49
Neutral
$1.84B-0.09%2.13%-4.49%-100.80%
47
Neutral
$976.01M-4.15%7.75%-302.73%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SCL
Stepan Company
44.17
-29.16
-39.77%
IOSP
Innospec
74.09
-41.49
-35.90%
MTX
Minerals Technologies
57.22
-22.45
-28.18%
ODC
Oil-Dri Of America
57.09
23.38
69.36%
REX
Rex American
33.23
10.08
43.54%
ECVT
Ecovyst
8.56
0.48
5.94%

Stepan Company Corporate Events

Stepan Company Reports Mixed Q3 2025 Results
Oct 30, 2025

Stepan Company, a leading manufacturer of specialty and intermediate chemicals, operates primarily in the surfactants and polymers industries, providing essential ingredients for consumer and industrial cleaning products, as well as polyurethane polyols for thermal insulation and CASE industries.

Stepan Company Earnings Call: Mixed Results and Future Focus
Oct 30, 2025

Stepan Company’s latest earnings call painted a mixed picture of its financial performance. While the company celebrated significant achievements in adjusted EBITDA growth and the success of its specialty products segment, it also faced notable challenges, particularly in its surfactants segment. The call highlighted a sharp decline in adjusted net income, primarily due to tax and depreciation impacts.

DividendsFinancial Disclosures
Stepan Company Announces Quarterly Dividend Amid Income Drop
Negative
Oct 29, 2025

On October 29, 2025, Stepan Company announced a quarterly cash dividend of $0.395 per share, payable on December 15, 2025. The company’s third-quarter results showed a 54% decrease in net income to $10.8 million, despite a 6% increase in adjusted EBITDA to $56.2 million. The decline was attributed to higher tax rates and interest expenses, alongside increased costs from the start-up of a new site in Pasadena, Texas. However, global sales volume rose by 1%, and free cash flow improved to $40.2 million, driven by reduced working capital. The company experienced growth in several strategic markets, including polymers and specialty products, despite challenges in the consumer products segment.

The most recent analyst rating on (SCL) stock is a Hold with a $53.00 price target. To see the full list of analyst forecasts on Stepan Company stock, see the SCL Stock Forecast page.

Executive/Board Changes
Stepan Company Announces Resignation of Key Executive
Neutral
Oct 14, 2025

On October 10, 2025, Stepan Company announced the resignation of Samuel S. Hinrichsen, who served as Vice President and Interim Chief Financial Officer from October 30, 2024, to July 15, 2025, and later as Global Vice President, Finance and Investor Relations. His resignation, effective October 31, 2025, was not due to any disagreements with the company’s operations, policies, or practices. Stepan expressed gratitude for his contributions during his tenure.

The most recent analyst rating on (SCL) stock is a Hold with a $53.00 price target. To see the full list of analyst forecasts on Stepan Company stock, see the SCL Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 06, 2025